Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 3
1976 4
1977 5
1978 4
1979 2
1980 8
1981 5
1982 8
1983 21
1984 9
1985 13
1986 14
1987 24
1988 11
1989 25
1990 14
1991 16
1992 20
1993 19
1994 18
1995 28
1996 22
1997 25
1998 36
1999 29
2000 21
2001 14
2002 38
2003 51
2004 35
2005 46
2006 34
2007 43
2008 58
2009 56
2010 47
2011 47
2012 65
2013 77
2014 84
2015 96
2016 106
2017 119
2018 128
2019 107
2020 126
2021 130
2022 103
2023 106
2024 52

Text availability

Article attribute

Article type

Publication date

Search Results

1,911 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Hypertrophic cardiomyopathy 10"
Page 1
Hypertrophic cardiomyopathy: a systematic review.
Maron BJ. Maron BJ. JAMA. 2002 Mar 13;287(10):1308-20. doi: 10.1001/jama.287.10.1308. JAMA. 2002. PMID: 11886323 Review.
CONTEXT: Throughout the past 40 years, a vast and sometimes contradictory literature has accumulated regarding hypertrophic cardiomyopathy (HCM), a genetic cardiac disease caused by a variety of mutations in genes encoding sarcomeric proteins and characterized by a …
CONTEXT: Throughout the past 40 years, a vast and sometimes contradictory literature has accumulated regarding hypertrophic cardio …
Hypertrophic Obstructive Cardiomyopathy.
Batzner A, Schäfers HJ, Borisov KV, Seggewiß H. Batzner A, et al. Dtsch Arztebl Int. 2019 Jan 25;116(4):47-53. doi: 10.3238/arztebl.2019.0047. Dtsch Arztebl Int. 2019. PMID: 30855006 Free PMC article. Review.
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is caused by mutations in a number of genes. ...Septum ablation is associated with low perioperative and peri-interventional mortality but necessitates permanent pacemaker implantation in 10-20% of patients. CONCL …
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is caused by mutations in a number of genes. ...Septum ablation is associated wi …
Genome-wide association analysis of left ventricular imaging-derived phenotypes identifies 72 risk loci and yields genetic insights into hypertrophic cardiomyopathy.
Ning C, Fan L, Jin M, Wang W, Hu Z, Cai Y, Chen L, Lu Z, Zhang M, Chen C, Li Y, Zhang F, Wang W, Liu Y, Chen S, Jiang Y, He C, Wang Z, Chen X, Li H, Li G, Ma Q, Geng H, Tian W, Zhang H, Liu B, Xia Q, Yang X, Liu Z, Li B, Zhu Y, Li X, Zhang S, Tian J, Miao X. Ning C, et al. Nat Commun. 2023 Nov 30;14(1):7900. doi: 10.1038/s41467-023-43771-5. Nat Commun. 2023. PMID: 38036550 Free PMC article.

Genome-wide association studies of CMR-derived 12 LVRWTs identified 72 significant genetic loci associated with at least one LVRWT phenotype (P < 5 10(-8)), which were revealed to actively participate in heart development and contraction pathways. Significant causal rel

…
Genome-wide association studies of CMR-derived 12 LVRWTs identified 72 significant genetic loci associated with at least one LVRWT phenotype …
Patterns of Replacement Fibrosis in Hypertrophic Cardiomyopathy.
Liu J, Zhao S, Yu S, Wu G, Wang D, Liu L, Song J, Zhu Y, Kang L, Wang J, Song L. Liu J, et al. Radiology. 2022 Feb;302(2):298-306. doi: 10.1148/radiol.2021210914. Epub 2021 Nov 2. Radiology. 2022. PMID: 34726536
Background Myocardial replacement fibrosis is one of the major histologic features of hypertrophic cardiomyopathy (HCM), but its characteristics have not been well delineated. ...Conclusion In hypertrophic cardiomyopathy, myocardial replacement fibrosi …
Background Myocardial replacement fibrosis is one of the major histologic features of hypertrophic cardiomyopathy (HCM), but i …
New Developments in Hypertrophic Cardiomyopathy.
Cooper RM, Raphael CE, Liebregts M, Anavekar NS, Veselka J. Cooper RM, et al. Can J Cardiol. 2017 Oct;33(10):1254-1265. doi: 10.1016/j.cjca.2017.07.007. Epub 2017 Jul 20. Can J Cardiol. 2017. PMID: 28941606 Review.
Hypertrophic cardiomyopathy is the leading cause of sudden death in young individuals and an important cause of heart failure at any age. ...Myocardial perfusion abnormalities are known to predict adverse outcome in hypertrophic cardiomyopathy and we d …
Hypertrophic cardiomyopathy is the leading cause of sudden death in young individuals and an important cause of heart failure …
Update on hypertrophic cardiomyopathy and a guide to the guidelines.
Sen-Chowdhry S, Jacoby D, Moon JC, McKenna WJ. Sen-Chowdhry S, et al. Nat Rev Cardiol. 2016 Nov;13(11):651-675. doi: 10.1038/nrcardio.2016.140. Epub 2016 Sep 29. Nat Rev Cardiol. 2016. PMID: 27681577 Review.
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disorder, affecting 1 in 500 individuals worldwide. ...
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disorder, affecting 1 in 500 individuals worldwi …
Hypokinetic hypertrophic cardiomyopathy: clinical phenotype, genetics, and prognosis.
Wasserstrum Y, Larrañaga-Moreira JM, Martinez-Veira C, Itelman E, Lotan D, Sabbag A, Kuperstein R, Peled Y, Freimark D, Barriales-Villa R, Arad M. Wasserstrum Y, et al. ESC Heart Fail. 2022 Aug;9(4):2301-2312. doi: 10.1002/ehf2.13914. Epub 2022 Apr 30. ESC Heart Fail. 2022. PMID: 35488723 Free PMC article.
AIMS: To describe the phenotype, genetics, and events associated with the development of hypertrophic cardiomyopathy (HCM) with reduced ventricular function (HCMr). ...Patients who developed HCMr in the course of the study had similar mortality but a higher rate of …
AIMS: To describe the phenotype, genetics, and events associated with the development of hypertrophic cardiomyopathy (HCM) wit …
Genetic profile and genotype-phenotype correlations in childhood cardiomyopathy.
Wanert C, El Louali F, Al Dybiat S, Nguyen K, Zaffran S, Ovaert C. Wanert C, et al. Arch Cardiovasc Dis. 2023 Jun-Jul;116(6-7):309-315. doi: 10.1016/j.acvd.2023.04.008. Epub 2023 May 16. Arch Cardiovasc Dis. 2023. PMID: 37246080 Free article.
All data (clinical, echocardiography, genetic testing) were collected retrospectively. Patients were classified into six groups: hypertrophic cardiomyopathy; dilated cardiomyopathy; restrictive cardiomyopathy; left ventricular non-compaction; arrhythmo …
All data (clinical, echocardiography, genetic testing) were collected retrospectively. Patients were classified into six groups: hypertro …
Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy.
Norrish G, Cleary A, Field E, Cervi E, Boleti O, Ziółkowska L, Olivotto I, Khraiche D, Limongelli G, Anastasakis A, Weintraub R, Biagini E, Ragni L, Prendiville T, Duignan S, McLeod K, Ilina M, Fernandez A, Marrone C, Bökenkamp R, Baban A, Kubus P, Daubeney PEF, Sarquella-Brugada G, Cesar S, Klaassen S, Ojala TH, Bhole V, Medrano C, Uzun O, Brown E, Gran F, Sinagra G, Castro FJ, Stuart G, Yamazawa H, Barriales-Villa R, Garcia-Guereta L, Adwani S, Linter K, Bharucha T, Gonzales-Lopez E, Siles A, Rasmussen TB, Calcagnino M, Jones CB, De Wilde H, Kubo T, Felice T, Popoiu A, Mogensen J, Mathur S, Centeno F, Reinhardt Z, Schouvey S, Elliott PM, Kaski JP. Norrish G, et al. J Am Coll Cardiol. 2022 May 24;79(20):1986-1997. doi: 10.1016/j.jacc.2022.03.347. J Am Coll Cardiol. 2022. PMID: 35589160 Free PMC article.
BACKGROUND: Up to one-half of childhood sarcomeric hypertrophic cardiomyopathy (HCM) presents before the age of 12 years, but this patient group has not been systematically characterized. OBJECTIVES: The aim of this study was to describe the clinical presentation an …
BACKGROUND: Up to one-half of childhood sarcomeric hypertrophic cardiomyopathy (HCM) presents before the age of 12 years, but …
The sex gap in hypertrophic cardiomyopathy.
Montenegro Sá F, Oliveira M, Belo A, Correia J, Azevedo O, Morais J; Portuguese Registry of Hypertrophic Cardiomyopathy investigators. Montenegro Sá F, et al. Rev Esp Cardiol (Engl Ed). 2020 Dec;73(12):1018-1025. doi: 10.1016/j.rec.2020.01.007. Epub 2020 Feb 28. Rev Esp Cardiol (Engl Ed). 2020. PMID: 32115394 English, Spanish.
INTRODUCTION AND OBJECTIVES: Key sex differences have been explored in multiple cardiac conditions. However, sex impact in hypertrophic cardiomyopathy outcome is unclear. We aimed to characterize sex impact in overall and cardiovascular (CV) mortality in a nationwid …
INTRODUCTION AND OBJECTIVES: Key sex differences have been explored in multiple cardiac conditions. However, sex impact in hypertrophic …
1,911 results